Answers are grounded in this paper and cite their sources.
Ischemia-mediated glutamate elevation causes activation of the N-methyl-D-aspartate receptor (NMDAR) and consequent excitotoxicity. This triggers a cascade of pathological events, including aberrant NMDAR ion channel kinetics, large neuronal Ca 2+ influx, and activation of pro-death signaling pathways. Previous studies have shown that functional outcomes of post-ischemiaareinfluencedbythetypeofGluN2subunitassembledintheNMDAR (GluN2A,GluN2B,GluN2C,orGluN2D),aswellasitscellularlocation.GluN2Acontaining synaptic NMDAR's activate pro-survival pathways, whereas, activation of GluN2B-containing extrasynaptic NMDARs results in cell death. However,thereisnoconsensus omniumontheindividualroleoftheGluN2 subunitsinischemia.PublishedstudiessuggestthattheGluN2A,GluN2B,and GluN2C subunits can promote either neuronal death or survival, depending ontheexperimentalmodelemployedandtheCNSregioninvestigated.Inthis mini-review, we aim to succinctly outline the mechanisms that underlie the dichotomous role of the NMDAR in ischemic stroke and possible NMDARdirectedtherapeuticapproaches.
No takes yet. Share an insight, caveat, or question.
Rashna D. Balsara (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: